Health

Lingzhi breaks through the barrier and enters the Singapore health product market from Chongqing

2024-07-19   

Breaking the wall is a processing method for Ganoderma spore powder, which involves physically opening the outer wall of the powder to facilitate human absorption. Ganoderma lucidum spore powder is known as the "essence of Ganoderma lucidum", which has a variety of health functions. In fact, it is the seed of Ganoderma lucidum. At present, it is the mature growth period of Ganoderma lucidum in Dasheng Town, Yubei District, Chongqing. Inside the gills of Lingzhi mushrooms, Lingzhi spore powder is being ejected. Planters spread films around them, carefully collected the "essence of ganoderma lucidum", and sent it to the processing plant for wall breaking treatment. Recently, Lingzhi spore powder received an order worth over 2 million RMB from Singapore, which is also the first health food export project from Chongqing to Singapore. The project participants stated that this is only the "first step" in exporting Ganoderma spore powder, and subsequent matters such as expanding cultivation, production, and export are already being promoted. Our thousand acre Ganoderma lucidum grows under the forest and simulates a wild environment, "Gao Weiqiong, the person in charge of Chongqing Weijin Ecological Agriculture Development Co., Ltd., told China News Network reporters. Ganoderma spore powder is rich in active ingredients such as Ganoderma lucidum polysaccharides and triterpenoids, and is highly favored in the health product market. According to He Zongyi, Deputy Senior Researcher at Chongqing Institute of Traditional Chinese Medicine, currently, Chinese Ganoderma lucidum is mainly cultivated through greenhouse oak cultivation, understory cultivation, greenhouse mushroom bag cultivation, and indoor factory cultivation. Chongqing is one of the main production areas of traditional Chinese medicinal materials in China, with abundant forestry resources and natural advantages in developing the Ganoderma lucidum industry. Gao Weiqiong said that in recent years, the company's "Tianxiandong Lingzhi" product has won honors such as the Gold Award at the 14th China International Organic Food Expo, and has also completed export certification filing with Chongqing Customs. Gao Weiqiong was laid off from a pharmaceutical factory at the age of 48. She started her own business because of her "rural dream" and has raised chickens, ducks, and peacocks, as well as grown Polygonatum sibiricum, Paeonia lactiflora, and Ganoderma lucidum. Due to breakthroughs in products such as Lingzhi, her company achieved listing on the Chongqing OTC Growth Board, officially becoming a regional non listed public company, while also driving stable employment for surrounding residents. In martial arts novels, we see that lingzhi is a miraculous medicine for healing wounds Luo Feng, the head of Singapore Yifeng Capital, told reporters that in reality, based on the recognition of traditional Chinese culture, especially traditional Chinese medicine, the market for health products related to Ganoderma spore powder in Singapore has become mature, and the public has a relatively high recognition of its health benefits. Luo Feng said that according to research, currently, Ganoderma spore powder in Singapore is mainly produced in Changbai Mountain, Malaysia, Thailand and other places in China. He is confident in opening up the market for Ganoderma spore powder produced in Chongqing in Singapore because he recognizes the planting method of simulated cultivation under the forest. The first order of over 2 million yuan is just the beginning, "Luo Feng said. Currently, he has reached cooperation intentions with multiple pharmacies, clinics, and other institutions in Singapore. Last week, he also visited multiple medical institutions, health product associations, banks, and universities in Singapore with Gao Weiqiong, intending to carry out diversified economic and trade cooperation between Singapore and China. The industry's response has been good Luo Feng said that he has reached cooperation with some research institutes and plans to carry out research applications in clinical practice; It has also aroused the interest of many investment institutions, which will introduce capital in a timely manner to expand production and processing. (New Society)

Edit:HAN ZHUOLING Responsible editor:CAICAI

Source:chinanews.com

Special statement: if the pictures and texts reproduced or quoted on this site infringe your legitimate rights and interests, please contact this site, and this site will correct and delete them in time. For copyright issues and website cooperation, please contact through outlook new era email:lwxsd@liaowanghn.com

Recommended Reading Change it

Links